Antimicrobial agent | MRSA (n = 61) | P # | MSSA (n = 30) | P # | ||||
---|---|---|---|---|---|---|---|---|
R | I | S | R | I | S | |||
Cefoxitin | 61 | 0 | 0 | 0.004 | 0 | 0 | 30 | 0.025 |
Gentamycin | 38 | 8 | 16 | 0.03 | 1 | 0 | 29 | 0.012 |
Erythromycin | 19 | 16 | 6 | 0.03 | 0 | 0 | 30 | 0.025 |
Amikacin | 11 | 18 | 32 | 0.12 | 0 | 0 | 30 | 0.025 |
Ciprofloxacin | 33 | 12 | 16 | 0.021 | 0 | 0 | 30 | 0.025 |
Clindamycin | 19 | 13 | 29 | 0.022 | 0 | 0 | 30 | 0.025 |
Chloramphenicol | 8 | 16 | 37 | 0.65 | 7 | 0 | 23 | 0.65 |
Linezolid | 8 | 19 | 34 | 0.040 | 0 | 0 | 30 | 0.025 |
Daptomycin | 11 | 0 | 50 | 0.79 | 0 | 0 | 30 | 0.025 |
Penicillin | 61 | 0 | 0 | 0.001 | 13 | 9 | 8 | 0.059 |
Gatifloxacin | 40 | 11 | 12 | 0.025 | 9 | 1 | 20 | 0.025 |
Trimethoprim/sulfamethoxazole | 11 | 0 | 50 | 0.82 | 0 | 0 | 30 | 0.025 |
MDR | 56 | 0.051 | 4 | 0.95 | ||||
XDR | 24 | 0.072 | 0 | – | ||||
PDR | 8 | 0.22 | 0 | – | ||||
SCCmec types | ||||||||
SCCmecI | 10 | 0.019 | 0 | – | ||||
SCCmecII | 14 | 0.041 | 0 | – | ||||
SCCmecIII | 24 | 0.020 | 0 | – | ||||
SCCmecIV | 13 | 0.008 | 0 | – | ||||
SCCmecV | 10 | 0.045 | 0 | – | ||||
Virulence factor genes | ||||||||
tst | 19 | 0.021 | 0 | – | ||||
etA | 11 | 0.001 | 0 | – | ||||
etB | 5 | 0.071 | 0 | – | ||||
lukS-PVL | 19 | 0.035 | 0 | – | ||||
lukF-PV | 11 | 0.040 | 0 | – | ||||
lukE-lukD | 10 | 0.055 | 0 | – | ||||
edinA | 2 | 0.037 | 0 | – | ||||
hla | 10 | 0.111 | 0 | – | ||||
hlb | 13 | 0.018 | 0 | – | ||||
hld | 9 | 0.068 | 0 | – | ||||
hlg | 14 | 0.018 | 0 | – |